
Also known as Tirz
Dual GIP / GLP-1 receptor agonist — Tirzepatide vials in 20mg, 40mg and 60mg UK stock. 99%+ purity, prepared for in vitro incretin research.
Best value and fastest option — supplied as a lyophilised vial, shipped the same day when ordered by 1pm, Monday to Friday.
For In Vitro Use Only — Not for Human Use
Factory independent testing is reviewed for every batch, and we go the extra mile with our own independent HPLC & mass-spec testing in Europe. Where our certificate has been published, it is batch-numbered so you can match it to your vial.
Tirzepatide is a 39-amino-acid dual agonist that binds both the GIP and GLP-1 receptors from a single peptide backbone, with a C20 fatty-diacid moiety that extends its half-life in solution. Supplied as a sterile lyophilised powder in 20mg, 40mg and 60mg vials, verified to 99%+ purity by RP-HPLC and confirmed by mass spectrometry. All three vial sizes are held in UK stock and dispatch the same day when ordered by 1pm, Monday to Friday.
In vitro, Tirzepatide is used to characterise co-activation of the GIP and GLP-1 receptors — including cAMP accumulation, β-arrestin recruitment and receptor-bias studies. It is often used as a comparator peptide when characterising newer molecules such as Retatrutide or Cagrilintide combinations.